Skip to content

Clinical trials

Completed Immunoblastic Lymphadenopathy trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Immunoblastic Lymphadenopathy Status: Completed Clear all

173 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
200012
20018
20028
20039
20048
200510
20068
200713
200811
20098
201010
201110
20123
20132
20144
20152
20162
20172
20182
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed173

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)34
Fred Hutchinson Cancer Center12
Mayo Clinic9
Memorial Sloan Kettering Cancer Center9
Case Comprehensive Cancer Center6
National Institutes of Health Clinical Center (CC)6
European Organisation for Research and Treatment of Cancer - EORTC5
Northwestern University5
Roswell Park Cancer Institute5
Wake Forest University Health Sciences5

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Immunoblastic Lymphadenopathy173
Lymphoma, Large-Cell, Anaplastic165
Lymphoma, Large B-Cell, Diffuse145
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma141
Lymphoma, Follicular140
Lymphoma, Mantle-Cell139
Burkitt Lymphoma137
Lymphoma, B-Cell, Marginal Zone135
Leukemia, Lymphocytic, Chronic, B-Cell134
Precursor Cell Lymphoblastic Leukemia-Lymphoma134

Trials

Showing 51 to 75 of 173. Each trial links to its page on Pharma Observatory.

73 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.